Complications in dental implantation with special consideration of anticoagulated patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027941

Enrollment

300

Registered

2022-02-01

Start date

2017-10-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K00.0 Z92.1 Z92.2

Interventions

Group 1: Patients with dental implantation without anticoagulation or antiplatelet therapy Group 2: Patients with dental implantation with anticoagulation and / or antiplatelet therapy

Eligibility

Sex/Gender

All

Age

18 Years to 111 Years

Inclusion criteria

Inclusion criteria: Patients aged 18 and over All consecutive patients with at least one dental implant placed Observational period 2014-2017

Exclusion criteria

Exclusion criteria: Patients younger than 18 years Patients with status after malignant head and neck tumors with bony reconstruction Status after primary or adjuvant radiation or chemotherapy in the head and neck area Antiresorptive medication (bisphosphonates, RANK-L inhibitors) Patients undergoing bone augmentation at the same time palatal implants for orthodontic purposes

Design outcomes

Primary

Measure	Time frame
Occurrence of a complication: bleeding, infection, nerve injury, implant loss	—

Secondary

Measure	Time frame
Success rate of osseointegration	—

Countries

Germany

Contacts

Public ContactMichael Ermer

Uniklinik Freiburg Klinik für MKG Chirurgie

michael.ermer@uniklinik-freiburg.de076127047010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026